The company reported strong revenue and net profit growth in 3Q25, supported by high profitability and a robust capital position. The non-life and health segments demonstrated dynamic growth, while strategic initiatives and innovation continue to underpin future expansion. Market share and solvency levels remain industry-leading, reflecting the company’s solid operational and financial strength.